Stay updated on Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T06:04:07.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:20:44.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The webpage has undergone significant changes, including the removal of detailed information about a clinical trial for CD30+ lymphoma treatments and the addition of new identifiers and a location for a study. The revision number has also been updated.
    Difference
    38%
    Check dated 2025-04-16T10:33:17.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 10, 2025.
    Difference
    0.3%
    Check dated 2025-04-09T05:01:01.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page has been updated to reflect that the study is currently active and not recruiting, with new relevant dates for the study timeline. Additionally, contact information for the principal investigator has been removed.
    Difference
    3%
    Check dated 2025-03-11T00:49:03.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T20:09:02.000Z thumbnail image

Stay in the know with updates to Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Brentuximab Vedotin ± Nivolumab in CD30+ Lymphoma Clinical Trial page.